Skip to content


  • Poster presentation
  • Open Access

Effect of cyproheptadine on combat related PTSD nightmares

  • Gholamhossien Ahmadzadeh1,
  • Ghorbanali Asadolahi1,
  • Gavad Mahmodi1 and
  • Arezoo Farhat1
Annals of General Psychiatry20065(Suppl 1):S159

Published: 28 February 2006


Public HealthPatient StudyStress DisorderTrazodoneOpen Trial


Recent studies have shown the role serotonergic system in post-traumatic stress disorder. Trazodone and Nefazodone (5H2 antagonist) amilorated PTSD nightmares but the receptors are mixed. This study promoted an open trial of cyporoheptadine for Iran versus Iraq combat related PTSD patients nightmares.

Materials and methods

25 patients studies in 8 week, before after trial of cyproheptadine, the participant were male and chronic PTSD patients with combat related nightmares.


5 patients were excluded from the study because of side effects including dizziness and somnolence. 20 patients completed the study. Average nightmare severity decreased from 6.85 to 5.05 which was statistically signifcant (p < 0.01).


Cyproheptadine may be effective in PTSD nightmare treatment.

Authors’ Affiliations

Behavioral Science Research Center, Khorshid Medical Center Esfahan, Iran


  1. Harsh HH: Cyorheptatine for recurrent nighmares. Am J Psy. 1986, 143: 1491-1492.View ArticleGoogle Scholar


© The Author(s) 2006